Form 8-K - Current report:
SEC Accession No. 0001193125-24-080804
Filing Date
2024-03-28
Accepted
2024-03-28 16:54:35
Documents
15
Period of Report
2024-03-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d798997d8k.htm   iXBRL 8-K 25161
2 EX-5.1 d798997dex51.htm EX-5.1 8595
6 GRAPHIC g798997g0328234954870.jpg GRAPHIC 2196
  Complete submission text file 0001193125-24-080804.txt   158924

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20240328.xsd EX-101.SCH 2842
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20240328_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20240328_pre.xml EX-101.PRE 10807
19 EXTRACTED XBRL INSTANCE DOCUMENT d798997d8k_htm.xml XML 3533
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 24800012
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)